- Home
- PEB vs GHRS Comparison
PEB vs GHRS Comparison
Compare PEB & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PEB | GHRS |
|---|---|---|
| Founded | 2009 | 2018 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.0B |
| IPO Year | 2009 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PEB | GHRS |
|---|---|---|
| Price | $19.12 | $21.07 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 16 | 10 |
| Target Price | $19.25 | ★ $42.89 |
| AVG Volume (30 Days) | ★ 2.0M | 268.4K |
| Earning Date | 10-29-2026 | 11-05-2026 |
| Dividend Yield | ★ 0.21% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,475,544,000.00 | N/A |
| Revenue This Year | $0.56 | N/A |
| Revenue Next Year | $2.02 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1.53 | N/A |
| 52 Week Low | $9.99 | $12.04 |
| 52 Week High | $19.93 | $31.44 |
Technical Indicators
Market Signals| Indicator | PEB | GHRS |
|---|---|---|
| Relative Strength Index (RSI) | 62.39 | 29.00 |
| Support Level | $17.50 | $19.75 |
| Resistance Level | $19.73 | $22.88 |
| Average True Range (ATR) | 0.45 | 1.36 |
| MACD | 0.06 | -0.39 |
| Stochastic Oscillator | 81.29 | 14.39 |
Price Performance
Historical ComparisonAbout PEB Pebblebrook Hotel Trust of Beneficial Interest
Pebblebrook Hotel Trust currently owns upper upscale and luxury hotels with 11,052 rooms across 44 hotels in the United States. Pebblebrook acquired LaSalle Hotel Properties, which owned 10,451 rooms across 41 US hotels, in November 2018, though management has sold many of those hotels over the past few years. Pebblebrook's portfolio consists mostly of independent hotels with no brand affiliations, though the combined company does own and operate some hotels under the Marriott, Starwood, InterContinental, Hilton, and Hyatt brands.
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.